Patent Law FAQ

This FAQ answers all your questions about patent law, patent procedure, and the patent examination process.

c Expand All C Collapse All

MPEP 140-Foreign Filing Licenses (1)

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

MPEP 200 – Types and Status of Application; Benefit and Priority (3)

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

MPEP 2000 – Duty Of Disclosure (1)

An Information Disclosure Statement (IDS) is a formal document submitted to the USPTO during patent prosecution to disclose relevant prior art or other material information. According to 37 CFR 1.97, as referenced in the MPEP, The provisions of 37 CFR 1.97 specify when an information disclosure statement will be considered as a matter of right and when a certification must be made and/or fee submitted in order to have the information disclosure statement considered.

The IDS is a crucial part of fulfilling the duty of disclosure to the USPTO, ensuring that the patent examiner has all relevant information when considering the patentability of an invention.

To learn more:

MPEP 2003 – Disclosure — When Made (1)

An Information Disclosure Statement (IDS) is a formal document submitted to the USPTO during patent prosecution to disclose relevant prior art or other material information. According to 37 CFR 1.97, as referenced in the MPEP, The provisions of 37 CFR 1.97 specify when an information disclosure statement will be considered as a matter of right and when a certification must be made and/or fee submitted in order to have the information disclosure statement considered.

The IDS is a crucial part of fulfilling the duty of disclosure to the USPTO, ensuring that the patent examiner has all relevant information when considering the patentability of an invention.

To learn more:

MPEP 201 – Types of Applications (2)

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

MPEP 2100 – Patentability (1)

The United States Patent and Trademark Office (USPTO) uses several criteria to determine if a claim is too broad. According to MPEP 2173.04, the assessment depends on the specific issues with the claim:

  1. Inventor’s Regard: If the claim is broader than what the inventor regards as the invention, it may be rejected under 35 U.S.C. 112(b).
  2. Lack of Support or Enablement: If the claim is not supported by the original description or lacks an enabling disclosure, it may be rejected under 35 U.S.C. 112(a).
  3. Prior Art: If the claim is so broad that it reads on prior art, it may be rejected under 35 U.S.C. 102 or 103.

The MPEP states: “Undue breadth of the claim may be addressed under different statutory provisions, depending on the reasons for concluding that the claim is too broad.

Examiners will analyze the claim language, specification, and prior art to make these determinations. It’s important to note that breadth alone does not make a claim too broad; the issue arises when the breadth leads to indefiniteness, lack of support, or overlap with prior art.

To learn more:

MPEP 2173.04 – Breadth Is Not Indefiniteness (1)

The United States Patent and Trademark Office (USPTO) uses several criteria to determine if a claim is too broad. According to MPEP 2173.04, the assessment depends on the specific issues with the claim:

  1. Inventor’s Regard: If the claim is broader than what the inventor regards as the invention, it may be rejected under 35 U.S.C. 112(b).
  2. Lack of Support or Enablement: If the claim is not supported by the original description or lacks an enabling disclosure, it may be rejected under 35 U.S.C. 112(a).
  3. Prior Art: If the claim is so broad that it reads on prior art, it may be rejected under 35 U.S.C. 102 or 103.

The MPEP states: “Undue breadth of the claim may be addressed under different statutory provisions, depending on the reasons for concluding that the claim is too broad.

Examiners will analyze the claim language, specification, and prior art to make these determinations. It’s important to note that breadth alone does not make a claim too broad; the issue arises when the breadth leads to indefiniteness, lack of support, or overlap with prior art.

To learn more:

MPEP 2200 – Citation Of Prior Art And Ex Parte Reexamination Of Patents (2)

For ex parte reexamination requests filed under 35 U.S.C. 302 and subsequent correspondence, the MPEP provides specific addressing instructions:

For mail sent via U.S. Postal Service:

  • Mail Stop “Ex Parte Reexam”
  • Attn: Central Reexamination Unit
  • Commissioner for Patents
  • P.O. Box 1450
  • Alexandria, VA 22313-1450

For hand-carried or delivery service submissions:

  • Customer Service Window
  • Randolph Building
  • 401 Dulany Street
  • Alexandria, VA 22314

The MPEP states: “It is strongly recommended that the Mail Stop information be placed in a prominent position on the first page of each paper being filed utilizing a sufficiently large font size that will direct attention to it.”

To learn more:

The concepts of a “substantial new question of patentability” (SNQ) and a “prima facie case of unpatentability” are distinct in patent law, particularly in the context of reexamination proceedings. According to MPEP 2242:

It is not necessary that a ‘prima facie’ case of unpatentability exist as to the claim in order for ‘a substantial new question of patentability’ to be present as to the claim.

Key differences include:

  • SNQ: This is the threshold for initiating a reexamination. It exists when prior art raises a substantial question about the patentability of at least one claim, even if it wouldn’t necessarily lead to a rejection.
  • Prima facie case: This is a higher standard, typically used during examination, where the evidence is sufficient to establish unpatentability unless rebutted.

The MPEP notes: Thus, ‘a substantial new question of patentability’ as to a patent claim could be present even if the examiner would not necessarily reject the claim as either fully anticipated by, or obvious in view of, the prior art patents or printed publications.

This distinction allows for a broader range of issues to be considered in reexamination proceedings.

To learn more:

MPEP 2224 – Correspondence (1)

For ex parte reexamination requests filed under 35 U.S.C. 302 and subsequent correspondence, the MPEP provides specific addressing instructions:

For mail sent via U.S. Postal Service:

  • Mail Stop “Ex Parte Reexam”
  • Attn: Central Reexamination Unit
  • Commissioner for Patents
  • P.O. Box 1450
  • Alexandria, VA 22313-1450

For hand-carried or delivery service submissions:

  • Customer Service Window
  • Randolph Building
  • 401 Dulany Street
  • Alexandria, VA 22314

The MPEP states: “It is strongly recommended that the Mail Stop information be placed in a prominent position on the first page of each paper being filed utilizing a sufficiently large font size that will direct attention to it.”

To learn more:

MPEP 2242 – Criteria For Deciding Request Filed Under 35 U.S.C. 302 (1)

The concepts of a “substantial new question of patentability” (SNQ) and a “prima facie case of unpatentability” are distinct in patent law, particularly in the context of reexamination proceedings. According to MPEP 2242:

It is not necessary that a ‘prima facie’ case of unpatentability exist as to the claim in order for ‘a substantial new question of patentability’ to be present as to the claim.

Key differences include:

  • SNQ: This is the threshold for initiating a reexamination. It exists when prior art raises a substantial question about the patentability of at least one claim, even if it wouldn’t necessarily lead to a rejection.
  • Prima facie case: This is a higher standard, typically used during examination, where the evidence is sufficient to establish unpatentability unless rebutted.

The MPEP notes: Thus, ‘a substantial new question of patentability’ as to a patent claim could be present even if the examiner would not necessarily reject the claim as either fully anticipated by, or obvious in view of, the prior art patents or printed publications.

This distinction allows for a broader range of issues to be considered in reexamination proceedings.

To learn more:

MPEP 2300 – Interference And Derivation Proceedings (1)

An interference in patent law is a proceeding to determine which party has the right to a patent when two or more parties claim the same invention. The Manual of Patent Examining Procedure (MPEP) Chapter 2300 covers interference and derivation proceedings.

According to MPEP 2304, “The suggestion for an interference may come from an applicant or from an examiner.” This process is crucial in determining priority of invention when multiple parties claim the same or similar inventions.

To learn more:

MPEP 2304 – Suggesting An Interference (1)

An interference in patent law is a proceeding to determine which party has the right to a patent when two or more parties claim the same invention. The Manual of Patent Examining Procedure (MPEP) Chapter 2300 covers interference and derivation proceedings.

According to MPEP 2304, “The suggestion for an interference may come from an applicant or from an examiner.” This process is crucial in determining priority of invention when multiple parties claim the same or similar inventions.

To learn more:

MPEP 2400 – Biotechnology (2)

When submitting a “Sequence Listing XML” in response to a notice from the United States International Searching Authority (ISA) or International Preliminary Examining Authority (IPEA), applicants are required to pay a late furnishing fee. According to MPEP 2414.05:

“In response to such a requirement, the late furnishing fee set forth in § 1.445(a)(5) is also required.”

This fee is in addition to the submission of the “Sequence Listing XML” and a statement that the information does not go beyond the original disclosure. The specific amount of the fee can be found in 37 CFR 1.445(a)(5) and is subject to change, so applicants should consult the current fee schedule on the USPTO website.

To learn more:

When submitting a “Sequence Listing XML” on read-only optical discs, proper labeling and packaging are crucial. According to MPEP 2413.03, follow these guidelines:

  1. Marking: All read-only optical discs, fees, and accompanying papers should be marked “Mail Stop SEQUENCE.”
  2. Hand delivery: For hand delivery to the Customer Service Window, place the disc in a protective mailer labeled with at least the application number (if available).
  3. Labeling requirements: Adhere to the labeling requirements of 37 CFR 1.52(e) and 1.834(b)(2).
  4. Packaging: Use staples and clips carefully to attach the mailer to the submitted papers without contacting or compressing the media.
  5. Multiple discs: If a compressed XML file doesn’t fit on a single disc, it may be split into multiple parts, labeled in compliance with § 1.52(e)(5)(vi).

The MPEP also states: “In no situations should additional or complimentary electronic copies be delivered to examiners or other Office personnel.”

By following these guidelines, you ensure proper handling and processing of your “Sequence Listing XML” submission.

To learn more:

MPEP 2413.03 – How To Submit The "Sequence Listing Xml" (1)

When submitting a “Sequence Listing XML” on read-only optical discs, proper labeling and packaging are crucial. According to MPEP 2413.03, follow these guidelines:

  1. Marking: All read-only optical discs, fees, and accompanying papers should be marked “Mail Stop SEQUENCE.”
  2. Hand delivery: For hand delivery to the Customer Service Window, place the disc in a protective mailer labeled with at least the application number (if available).
  3. Labeling requirements: Adhere to the labeling requirements of 37 CFR 1.52(e) and 1.834(b)(2).
  4. Packaging: Use staples and clips carefully to attach the mailer to the submitted papers without contacting or compressing the media.
  5. Multiple discs: If a compressed XML file doesn’t fit on a single disc, it may be split into multiple parts, labeled in compliance with § 1.52(e)(5)(vi).

The MPEP also states: “In no situations should additional or complimentary electronic copies be delivered to examiners or other Office personnel.”

By following these guidelines, you ensure proper handling and processing of your “Sequence Listing XML” submission.

To learn more:

MPEP 2500 – Maintenance Fees (1)

If you miss both the maintenance fee payment and the 6-month grace period, your patent will expire. However, the USPTO may accept late payments under certain conditions. According to MPEP 2501:

“The Director may accept the payment of any maintenance fee required by subsection (b) after the 6-month grace period if the delay is shown to the satisfaction of the Director to have been unintentional.”

To reinstate the patent, you must file a petition showing the delay was unintentional and pay the maintenance fee along with any required surcharges. If accepted, “the patent shall be considered as not having expired at the end of the grace period.”

To learn more:

MPEP 2501 – Introduction (1)

If you miss both the maintenance fee payment and the 6-month grace period, your patent will expire. However, the USPTO may accept late payments under certain conditions. According to MPEP 2501:

“The Director may accept the payment of any maintenance fee required by subsection (b) after the 6-month grace period if the delay is shown to the satisfaction of the Director to have been unintentional.”

To reinstate the patent, you must file a petition showing the delay was unintentional and pay the maintenance fee along with any required surcharges. If accepted, “the patent shall be considered as not having expired at the end of the grace period.”

To learn more:

MPEP 2800 – Supplemental Examination (3)

How do I update my address for patent correspondence with the USPTO?

To update your address for patent correspondence with the USPTO:

The MPEP states: “A patent owner’s change of address may be filed with the USPTO through the Office of Patent Legal Administration (OPLA).” (MPEP 2805)

Ensure you follow the proper procedures to maintain accurate communication channels with the USPTO regarding your patent.

To learn more:

When filing papers in an ex parte reexamination resulting from a supplemental examination, follow these guidelines as per MPEP 2806:

  • Use the USPTO’s Patent Electronic Filing System-Web (EFS-Web) or Patent Center for electronic filing.
  • For paper filings, send documents to: Mail Stop Ex Parte Reexam, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
  • Include the control number assigned to the reexamination proceeding.
  • Clearly mark all papers with “EX PARTE REEXAMINATION” to ensure proper routing.

The MPEP states: “Any paper filed in an ex parte reexamination proceeding resulting from a supplemental examination proceeding should be filed as provided in 37 CFR 1.1(c).” This ensures that your documents are properly processed and routed within the USPTO.

To learn more:

The USPTO determines if a Substantial New Question of Patentability (SNQ) is raised by reviewing the items of information presented in the supplemental examination request. The examiner considers whether the information would be important to a reasonable examiner in determining patentability.

According to the MPEP: For each item of information, the examiner need only identify one SNQ (e.g., a teaching that would be important to a reasonable examiner when determining patentability) for each identified claim. The determination is made on a claim-by-claim basis, and the examiner must provide a detailed explanation in the Reasons Document.

To learn more:

MPEP 2805 – Correspondence With Patent Owner; Patent Owner Address (1)

How do I update my address for patent correspondence with the USPTO?

To update your address for patent correspondence with the USPTO:

The MPEP states: “A patent owner’s change of address may be filed with the USPTO through the Office of Patent Legal Administration (OPLA).” (MPEP 2805)

Ensure you follow the proper procedures to maintain accurate communication channels with the USPTO regarding your patent.

To learn more:

MPEP 2806 – How To File Papers In A Supplemental Examination Proceeding And In Any Resulting Ex Parte Reexamination Proceeding (1)

When filing papers in an ex parte reexamination resulting from a supplemental examination, follow these guidelines as per MPEP 2806:

  • Use the USPTO’s Patent Electronic Filing System-Web (EFS-Web) or Patent Center for electronic filing.
  • For paper filings, send documents to: Mail Stop Ex Parte Reexam, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
  • Include the control number assigned to the reexamination proceeding.
  • Clearly mark all papers with “EX PARTE REEXAMINATION” to ensure proper routing.

The MPEP states: “Any paper filed in an ex parte reexamination proceeding resulting from a supplemental examination proceeding should be filed as provided in 37 CFR 1.1(c).” This ensures that your documents are properly processed and routed within the USPTO.

To learn more:

MPEP 2816.03 – Content Of The Determination (1)

The USPTO determines if a Substantial New Question of Patentability (SNQ) is raised by reviewing the items of information presented in the supplemental examination request. The examiner considers whether the information would be important to a reasonable examiner in determining patentability.

According to the MPEP: For each item of information, the examiner need only identify one SNQ (e.g., a teaching that would be important to a reasonable examiner when determining patentability) for each identified claim. The determination is made on a claim-by-claim basis, and the examiner must provide a detailed explanation in the Reasons Document.

To learn more:

MPEP 2900 – International Design Applications (3)

The timeline for submitting an Information Disclosure Statement (IDS) in an international design application designating the United States is outlined in MPEP 2920.05(f):

  1. At filing: An applicant may submit an IDS using Annex III to the official application form (DM/1 form) when filing the international design application.
  2. Preferred timing: “The Office would prefer to receive the IDS from the applicant after publication of the international registration.”
  3. Three-month window: According to 37 CFR 1.97(b)(5), “the IDS will be considered by the Office if filed by the applicant within three months of the date of publication of the international registration under Hague Agreement Article 10(3).”
  4. Later submissions: “The Office may also consider an IDS filed after this three month period as provided in 37 CFR 1.97.”

It’s important to note that while the USPTO will accept IDS submissions at various stages, submitting within the three-month window after publication ensures consideration without additional requirements. For IDS submissions outside this window, applicants should consult 37 CFR 1.97 for specific requirements and potential fees.

To learn more:

Information Disclosure Statement (IDS) requirements for international design applications designating the United States are similar to those for domestic national applications:

  • The duty to disclose information material to patentability applies to individuals associated with the filing and prosecution of the application.
  • An IDS must adhere to the requirements set forth in 37 CFR 1.97, 1.98, and 1.33(b) for consideration by the examiner.
  • An IDS filed within three months of the publication date of the international registration will be considered by the Office under 37 CFR 1.97(b)(5).
  • IDSs filed after this period may be considered as provided in 37 CFR 1.97.

As stated in the MPEP: An international design application designating the United States has the effect of a U.S. patent application and thus is subject to 37 CFR 1.56.

To learn more:

According to 37 CFR 1.1042, applicants can specify a correspondence address for communications sent by the USPTO as an office of indirect filing. The MPEP states:

Pursuant to 37 CFR 1.1042, the applicant may specify a correspondence address for correspondence sent by the USPTO as an office of indirect filing.

This address can be different from the one specified on the official DM/1 form used for filing the international design application. If no specific address is provided, the USPTO will use the address of the applicant’s appointed representative or the address specified in Administrative Instruction 302.

To learn more:

MPEP 2912 – Correspondence In Respect Of International Design Applications Filed With The Uspto As An Office Of Indirect Filing (1)

According to 37 CFR 1.1042, applicants can specify a correspondence address for communications sent by the USPTO as an office of indirect filing. The MPEP states:

Pursuant to 37 CFR 1.1042, the applicant may specify a correspondence address for correspondence sent by the USPTO as an office of indirect filing.

This address can be different from the one specified on the official DM/1 form used for filing the international design application. If no specific address is provided, the USPTO will use the address of the applicant’s appointed representative or the address specified in Administrative Instruction 302.

To learn more:

MPEP 2920.05 – Examination (1)

Information Disclosure Statement (IDS) requirements for international design applications designating the United States are similar to those for domestic national applications:

  • The duty to disclose information material to patentability applies to individuals associated with the filing and prosecution of the application.
  • An IDS must adhere to the requirements set forth in 37 CFR 1.97, 1.98, and 1.33(b) for consideration by the examiner.
  • An IDS filed within three months of the publication date of the international registration will be considered by the Office under 37 CFR 1.97(b)(5).
  • IDSs filed after this period may be considered as provided in 37 CFR 1.97.

As stated in the MPEP: An international design application designating the United States has the effect of a U.S. patent application and thus is subject to 37 CFR 1.56.

To learn more:

MPEP 2920.05(F) – Information Disclosure Statement In An International Design Application Designating The United States (1)

The timeline for submitting an Information Disclosure Statement (IDS) in an international design application designating the United States is outlined in MPEP 2920.05(f):

  1. At filing: An applicant may submit an IDS using Annex III to the official application form (DM/1 form) when filing the international design application.
  2. Preferred timing: “The Office would prefer to receive the IDS from the applicant after publication of the international registration.”
  3. Three-month window: According to 37 CFR 1.97(b)(5), “the IDS will be considered by the Office if filed by the applicant within three months of the date of publication of the international registration under Hague Agreement Article 10(3).”
  4. Later submissions: “The Office may also consider an IDS filed after this three month period as provided in 37 CFR 1.97.”

It’s important to note that while the USPTO will accept IDS submissions at various stages, submitting within the three-month window after publication ensures consideration without additional requirements. For IDS submissions outside this window, applicants should consult 37 CFR 1.97 for specific requirements and potential fees.

To learn more:

MPEP 300 – Ownership and Assignment (6)

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

MPEP 301-Ownership/Assignability of Patents and Applications (2)

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

MPEP 302 – Recording of Assignment Documents (2)

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

MPEP 303 – Assignment Documents Not Endorsed on Pending Applications (1)

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

MPEP 323 – Procedures for Correcting Errors in Recorded Assignment Document (1)

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

MPEP 400 – Representative of Applicant or Owner (8)

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

MPEP 402 – Power of Attorney; Naming Representative (2)

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

MPEP 500 – Receipt and Handling of Mail and Papers (2)

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

MPEP 509 – Payment of Fees (1)

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

Patent Law (42)

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

How do I update my address for patent correspondence with the USPTO?

To update your address for patent correspondence with the USPTO:

The MPEP states: “A patent owner’s change of address may be filed with the USPTO through the Office of Patent Legal Administration (OPLA).” (MPEP 2805)

Ensure you follow the proper procedures to maintain accurate communication channels with the USPTO regarding your patent.

To learn more:

The United States Patent and Trademark Office (USPTO) uses several criteria to determine if a claim is too broad. According to MPEP 2173.04, the assessment depends on the specific issues with the claim:

  1. Inventor’s Regard: If the claim is broader than what the inventor regards as the invention, it may be rejected under 35 U.S.C. 112(b).
  2. Lack of Support or Enablement: If the claim is not supported by the original description or lacks an enabling disclosure, it may be rejected under 35 U.S.C. 112(a).
  3. Prior Art: If the claim is so broad that it reads on prior art, it may be rejected under 35 U.S.C. 102 or 103.

The MPEP states: “Undue breadth of the claim may be addressed under different statutory provisions, depending on the reasons for concluding that the claim is too broad.

Examiners will analyze the claim language, specification, and prior art to make these determinations. It’s important to note that breadth alone does not make a claim too broad; the issue arises when the breadth leads to indefiniteness, lack of support, or overlap with prior art.

To learn more:

For ex parte reexamination requests filed under 35 U.S.C. 302 and subsequent correspondence, the MPEP provides specific addressing instructions:

For mail sent via U.S. Postal Service:

  • Mail Stop “Ex Parte Reexam”
  • Attn: Central Reexamination Unit
  • Commissioner for Patents
  • P.O. Box 1450
  • Alexandria, VA 22313-1450

For hand-carried or delivery service submissions:

  • Customer Service Window
  • Randolph Building
  • 401 Dulany Street
  • Alexandria, VA 22314

The MPEP states: “It is strongly recommended that the Mail Stop information be placed in a prominent position on the first page of each paper being filed utilizing a sufficiently large font size that will direct attention to it.”

To learn more:

An interference in patent law is a proceeding to determine which party has the right to a patent when two or more parties claim the same invention. The Manual of Patent Examining Procedure (MPEP) Chapter 2300 covers interference and derivation proceedings.

According to MPEP 2304, “The suggestion for an interference may come from an applicant or from an examiner.” This process is crucial in determining priority of invention when multiple parties claim the same or similar inventions.

To learn more:

The timeline for submitting an Information Disclosure Statement (IDS) in an international design application designating the United States is outlined in MPEP 2920.05(f):

  1. At filing: An applicant may submit an IDS using Annex III to the official application form (DM/1 form) when filing the international design application.
  2. Preferred timing: “The Office would prefer to receive the IDS from the applicant after publication of the international registration.”
  3. Three-month window: According to 37 CFR 1.97(b)(5), “the IDS will be considered by the Office if filed by the applicant within three months of the date of publication of the international registration under Hague Agreement Article 10(3).”
  4. Later submissions: “The Office may also consider an IDS filed after this three month period as provided in 37 CFR 1.97.”

It’s important to note that while the USPTO will accept IDS submissions at various stages, submitting within the three-month window after publication ensures consideration without additional requirements. For IDS submissions outside this window, applicants should consult 37 CFR 1.97 for specific requirements and potential fees.

To learn more:

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

An oath is a sworn statement made before a person authorized to administer oaths, while a declaration is a written statement that can be used in lieu of an oath. According to MPEP 602, “A declaration may be submitted in lieu of an oath in any document filed in the Office provided the declaration complies with the requirements of 37 CFR 1.68.” Declarations are often preferred because they don’t require appearing before an official and are easier to process electronically.

To learn more:

If you miss both the maintenance fee payment and the 6-month grace period, your patent will expire. However, the USPTO may accept late payments under certain conditions. According to MPEP 2501:

“The Director may accept the payment of any maintenance fee required by subsection (b) after the 6-month grace period if the delay is shown to the satisfaction of the Director to have been unintentional.”

To reinstate the patent, you must file a petition showing the delay was unintentional and pay the maintenance fee along with any required surcharges. If accepted, “the patent shall be considered as not having expired at the end of the grace period.”

To learn more:

The basic filing fee for a provisional application must be paid either:

  1. At the time of filing, or
  2. Within the time period set forth in 37 CFR 1.53(g)

If no correspondence address is provided, the applicant has two months from the filing date to pay the basic filing fee, submit the cover sheet, and pay the surcharge. The MPEP states:

If no correspondence address has been provided, applicant has two months from the filing date to file the basic filing fee, cover sheet, and to pay the surcharge as set forth in 37 CFR 1.16(g) in order to avoid abandonment of the provisional application. (MPEP 601.01(b))

It’s important to note that timely payment of the filing fee is crucial if you intend to claim the benefit of the provisional application in a later-filed nonprovisional application.

To learn more:

How does the USPTO define ‘new matter’ in patent applications?

The United States Patent and Trademark Office (USPTO) defines ‘new matter’ as any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. According to MPEP 608.04(a):

“Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.”

This definition is strict and encompasses any additions or modifications that introduce information not explicitly or inherently supported by the original disclosure. New matter can include:

  • Additional text in the specification
  • New or modified claim elements
  • Changes to drawings or the addition of new figures
  • Incorporation of external references not properly incorporated on the filing date

It’s important to note that new matter is prohibited under 35 U.S.C. 132(a), which states that “No amendment shall introduce new matter into the disclosure of the invention.”

To learn more:

An Information Disclosure Statement (IDS) is a mechanism by which patent applicants can comply with the duty of disclosure provided in 37 CFR 1.56. It allows applicants to submit information that is material to patentability to the U.S. Patent and Trademark Office (USPTO).

According to the MPEP, The provisions of 37 CFR 1.97 and 37 CFR 1.98 provide a mechanism by which patent applicants may comply with the duty of disclosure provided in 37 CFR 1.56 using an IDS. This means that an IDS is a formal way to disclose relevant prior art and other information to the patent examiner.

To learn more:

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

Can a power of attorney be filed after the patent application is submitted to the USPTO?

Yes, a power of attorney can be filed after the patent application is submitted to the USPTO. The MPEP 601.02 states:

“A power of attorney may be filed in a provisional application, a nonprovisional application, a reexamination proceeding, or a supplemental examination proceeding.”

This means that you can file a power of attorney at various stages of the patent process, including:

  • At the time of filing the application
  • After the application has been submitted
  • During prosecution of the application
  • Even after the patent has been granted (for reexamination or supplemental examination proceedings)

However, it’s generally advisable to file the power of attorney as early as possible to ensure smooth communication with the USPTO throughout the application process. If you need to file a power of attorney after submission, use the appropriate USPTO form and follow the current filing procedures.

To learn more:

The timing requirements for submitting an IDS are:

  • Within 3 months of filing or before first Office action, whichever is later
  • Before final Office action, Notice of Allowance, or Quayle action
  • After final Office action but before issue fee payment
  • After issue fee payment but before patent grant

The specific requirements vary based on when the IDS is filed. For example, as stated in MPEP 609.04(b): “An information disclosure statement will be considered by the examiner if filed within any one of the following time periods: (A) for national applications (not including CPAs), within three months of the filing date of the national application or before the mailing date of a first Office action on the merits; (B) for international applications, within three months of the date of entry of the national stage as set forth in 37 CFR 1.491 or before the mailing date of a first Office action on the merits; (C) for RCEs and CPAs, before the mailing date of a first Office action on the merits; or (D) for international design applications, within three months of the date of publication of the international registration under Hague Agreement Article 10(3) or before first Office action on the merits, whichever is later.”

To learn more:

Information Disclosure Statement (IDS) requirements for international design applications designating the United States are similar to those for domestic national applications:

  • The duty to disclose information material to patentability applies to individuals associated with the filing and prosecution of the application.
  • An IDS must adhere to the requirements set forth in 37 CFR 1.97, 1.98, and 1.33(b) for consideration by the examiner.
  • An IDS filed within three months of the publication date of the international registration will be considered by the Office under 37 CFR 1.97(b)(5).
  • IDSs filed after this period may be considered as provided in 37 CFR 1.97.

As stated in the MPEP: An international design application designating the United States has the effect of a U.S. patent application and thus is subject to 37 CFR 1.56.

To learn more:

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

An Information Disclosure Statement (IDS) is a formal document submitted to the USPTO during patent prosecution to disclose relevant prior art or other material information. According to 37 CFR 1.97, as referenced in the MPEP, The provisions of 37 CFR 1.97 specify when an information disclosure statement will be considered as a matter of right and when a certification must be made and/or fee submitted in order to have the information disclosure statement considered.

The IDS is a crucial part of fulfilling the duty of disclosure to the USPTO, ensuring that the patent examiner has all relevant information when considering the patentability of an invention.

To learn more:

Yes, you can request the return of your model, exhibit, or specimen from the USPTO. However, there are specific procedures and timeframes to follow. According to MPEP 608.03(a):

A request for return of the model, exhibit, or specimen should be made within the period set forth in MPEP § 608.03(a).

Here are the key points to remember:

  • Make the request before the application is allowed or within two months after the date of the Notice of Allowance.
  • Include a proper postage paid return address sticker with the request.
  • If the item is not claimed within the specified period, the USPTO may dispose of it at its discretion.

It’s important to act promptly if you wish to have your items returned, as the USPTO is not obligated to store them indefinitely.

To learn more:

Yes, in some cases, omitting information from a patent application can be considered new matter. This might seem counterintuitive, but the removal of certain information can change the scope or meaning of the invention in a way that wasn’t supported by the original disclosure.

The MPEP provides an example: New matter includes not only the addition of wholly unsupported subject matter, but may also include […] even the omission of a step from a method. (MPEP 608.04(a))

This concept is particularly important in the context of:

  • Changing the scope of the invention
  • Altering the nature of the invention
  • Removing essential features or steps

Applicants should be cautious when making any changes to their application, including deletions, to ensure they don’t inadvertently introduce new matter by omission. If in doubt, it’s advisable to consult with a patent attorney or agent.

To learn more:

Tags: new matter, USPTO

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

When filing papers in an ex parte reexamination resulting from a supplemental examination, follow these guidelines as per MPEP 2806:

  • Use the USPTO’s Patent Electronic Filing System-Web (EFS-Web) or Patent Center for electronic filing.
  • For paper filings, send documents to: Mail Stop Ex Parte Reexam, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
  • Include the control number assigned to the reexamination proceeding.
  • Clearly mark all papers with “EX PARTE REEXAMINATION” to ensure proper routing.

The MPEP states: “Any paper filed in an ex parte reexamination proceeding resulting from a supplemental examination proceeding should be filed as provided in 37 CFR 1.1(c).” This ensures that your documents are properly processed and routed within the USPTO.

To learn more:

The USPTO determines if a Substantial New Question of Patentability (SNQ) is raised by reviewing the items of information presented in the supplemental examination request. The examiner considers whether the information would be important to a reasonable examiner in determining patentability.

According to the MPEP: For each item of information, the examiner need only identify one SNQ (e.g., a teaching that would be important to a reasonable examiner when determining patentability) for each identified claim. The determination is made on a claim-by-claim basis, and the examiner must provide a detailed explanation in the Reasons Document.

To learn more:

When submitting a “Sequence Listing XML” in response to a notice from the United States International Searching Authority (ISA) or International Preliminary Examining Authority (IPEA), applicants are required to pay a late furnishing fee. According to MPEP 2414.05:

“In response to such a requirement, the late furnishing fee set forth in § 1.445(a)(5) is also required.”

This fee is in addition to the submission of the “Sequence Listing XML” and a statement that the information does not go beyond the original disclosure. The specific amount of the fee can be found in 37 CFR 1.445(a)(5) and is subject to change, so applicants should consult the current fee schedule on the USPTO website.

To learn more:

When submitting a “Sequence Listing XML” on read-only optical discs, proper labeling and packaging are crucial. According to MPEP 2413.03, follow these guidelines:

  1. Marking: All read-only optical discs, fees, and accompanying papers should be marked “Mail Stop SEQUENCE.”
  2. Hand delivery: For hand delivery to the Customer Service Window, place the disc in a protective mailer labeled with at least the application number (if available).
  3. Labeling requirements: Adhere to the labeling requirements of 37 CFR 1.52(e) and 1.834(b)(2).
  4. Packaging: Use staples and clips carefully to attach the mailer to the submitted papers without contacting or compressing the media.
  5. Multiple discs: If a compressed XML file doesn’t fit on a single disc, it may be split into multiple parts, labeled in compliance with § 1.52(e)(5)(vi).

The MPEP also states: “In no situations should additional or complimentary electronic copies be delivered to examiners or other Office personnel.”

By following these guidelines, you ensure proper handling and processing of your “Sequence Listing XML” submission.

To learn more:

According to 37 CFR 1.1042, applicants can specify a correspondence address for communications sent by the USPTO as an office of indirect filing. The MPEP states:

Pursuant to 37 CFR 1.1042, the applicant may specify a correspondence address for correspondence sent by the USPTO as an office of indirect filing.

This address can be different from the one specified on the official DM/1 form used for filing the international design application. If no specific address is provided, the USPTO will use the address of the applicant’s appointed representative or the address specified in Administrative Instruction 302.

To learn more:

The concepts of a “substantial new question of patentability” (SNQ) and a “prima facie case of unpatentability” are distinct in patent law, particularly in the context of reexamination proceedings. According to MPEP 2242:

It is not necessary that a ‘prima facie’ case of unpatentability exist as to the claim in order for ‘a substantial new question of patentability’ to be present as to the claim.

Key differences include:

  • SNQ: This is the threshold for initiating a reexamination. It exists when prior art raises a substantial question about the patentability of at least one claim, even if it wouldn’t necessarily lead to a rejection.
  • Prima facie case: This is a higher standard, typically used during examination, where the evidence is sufficient to establish unpatentability unless rebutted.

The MPEP notes: Thus, ‘a substantial new question of patentability’ as to a patent claim could be present even if the examiner would not necessarily reject the claim as either fully anticipated by, or obvious in view of, the prior art patents or printed publications.

This distinction allows for a broader range of issues to be considered in reexamination proceedings.

To learn more:

Patent Procedure (42)

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

How do I update my address for patent correspondence with the USPTO?

To update your address for patent correspondence with the USPTO:

The MPEP states: “A patent owner’s change of address may be filed with the USPTO through the Office of Patent Legal Administration (OPLA).” (MPEP 2805)

Ensure you follow the proper procedures to maintain accurate communication channels with the USPTO regarding your patent.

To learn more:

The United States Patent and Trademark Office (USPTO) uses several criteria to determine if a claim is too broad. According to MPEP 2173.04, the assessment depends on the specific issues with the claim:

  1. Inventor’s Regard: If the claim is broader than what the inventor regards as the invention, it may be rejected under 35 U.S.C. 112(b).
  2. Lack of Support or Enablement: If the claim is not supported by the original description or lacks an enabling disclosure, it may be rejected under 35 U.S.C. 112(a).
  3. Prior Art: If the claim is so broad that it reads on prior art, it may be rejected under 35 U.S.C. 102 or 103.

The MPEP states: “Undue breadth of the claim may be addressed under different statutory provisions, depending on the reasons for concluding that the claim is too broad.

Examiners will analyze the claim language, specification, and prior art to make these determinations. It’s important to note that breadth alone does not make a claim too broad; the issue arises when the breadth leads to indefiniteness, lack of support, or overlap with prior art.

To learn more:

For ex parte reexamination requests filed under 35 U.S.C. 302 and subsequent correspondence, the MPEP provides specific addressing instructions:

For mail sent via U.S. Postal Service:

  • Mail Stop “Ex Parte Reexam”
  • Attn: Central Reexamination Unit
  • Commissioner for Patents
  • P.O. Box 1450
  • Alexandria, VA 22313-1450

For hand-carried or delivery service submissions:

  • Customer Service Window
  • Randolph Building
  • 401 Dulany Street
  • Alexandria, VA 22314

The MPEP states: “It is strongly recommended that the Mail Stop information be placed in a prominent position on the first page of each paper being filed utilizing a sufficiently large font size that will direct attention to it.”

To learn more:

An interference in patent law is a proceeding to determine which party has the right to a patent when two or more parties claim the same invention. The Manual of Patent Examining Procedure (MPEP) Chapter 2300 covers interference and derivation proceedings.

According to MPEP 2304, “The suggestion for an interference may come from an applicant or from an examiner.” This process is crucial in determining priority of invention when multiple parties claim the same or similar inventions.

To learn more:

The timeline for submitting an Information Disclosure Statement (IDS) in an international design application designating the United States is outlined in MPEP 2920.05(f):

  1. At filing: An applicant may submit an IDS using Annex III to the official application form (DM/1 form) when filing the international design application.
  2. Preferred timing: “The Office would prefer to receive the IDS from the applicant after publication of the international registration.”
  3. Three-month window: According to 37 CFR 1.97(b)(5), “the IDS will be considered by the Office if filed by the applicant within three months of the date of publication of the international registration under Hague Agreement Article 10(3).”
  4. Later submissions: “The Office may also consider an IDS filed after this three month period as provided in 37 CFR 1.97.”

It’s important to note that while the USPTO will accept IDS submissions at various stages, submitting within the three-month window after publication ensures consideration without additional requirements. For IDS submissions outside this window, applicants should consult 37 CFR 1.97 for specific requirements and potential fees.

To learn more:

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

An oath is a sworn statement made before a person authorized to administer oaths, while a declaration is a written statement that can be used in lieu of an oath. According to MPEP 602, “A declaration may be submitted in lieu of an oath in any document filed in the Office provided the declaration complies with the requirements of 37 CFR 1.68.” Declarations are often preferred because they don’t require appearing before an official and are easier to process electronically.

To learn more:

If you miss both the maintenance fee payment and the 6-month grace period, your patent will expire. However, the USPTO may accept late payments under certain conditions. According to MPEP 2501:

“The Director may accept the payment of any maintenance fee required by subsection (b) after the 6-month grace period if the delay is shown to the satisfaction of the Director to have been unintentional.”

To reinstate the patent, you must file a petition showing the delay was unintentional and pay the maintenance fee along with any required surcharges. If accepted, “the patent shall be considered as not having expired at the end of the grace period.”

To learn more:

The basic filing fee for a provisional application must be paid either:

  1. At the time of filing, or
  2. Within the time period set forth in 37 CFR 1.53(g)

If no correspondence address is provided, the applicant has two months from the filing date to pay the basic filing fee, submit the cover sheet, and pay the surcharge. The MPEP states:

If no correspondence address has been provided, applicant has two months from the filing date to file the basic filing fee, cover sheet, and to pay the surcharge as set forth in 37 CFR 1.16(g) in order to avoid abandonment of the provisional application. (MPEP 601.01(b))

It’s important to note that timely payment of the filing fee is crucial if you intend to claim the benefit of the provisional application in a later-filed nonprovisional application.

To learn more:

How does the USPTO define ‘new matter’ in patent applications?

The United States Patent and Trademark Office (USPTO) defines ‘new matter’ as any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. According to MPEP 608.04(a):

“Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.”

This definition is strict and encompasses any additions or modifications that introduce information not explicitly or inherently supported by the original disclosure. New matter can include:

  • Additional text in the specification
  • New or modified claim elements
  • Changes to drawings or the addition of new figures
  • Incorporation of external references not properly incorporated on the filing date

It’s important to note that new matter is prohibited under 35 U.S.C. 132(a), which states that “No amendment shall introduce new matter into the disclosure of the invention.”

To learn more:

An Information Disclosure Statement (IDS) is a mechanism by which patent applicants can comply with the duty of disclosure provided in 37 CFR 1.56. It allows applicants to submit information that is material to patentability to the U.S. Patent and Trademark Office (USPTO).

According to the MPEP, The provisions of 37 CFR 1.97 and 37 CFR 1.98 provide a mechanism by which patent applicants may comply with the duty of disclosure provided in 37 CFR 1.56 using an IDS. This means that an IDS is a formal way to disclose relevant prior art and other information to the patent examiner.

To learn more:

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

Can a power of attorney be filed after the patent application is submitted to the USPTO?

Yes, a power of attorney can be filed after the patent application is submitted to the USPTO. The MPEP 601.02 states:

“A power of attorney may be filed in a provisional application, a nonprovisional application, a reexamination proceeding, or a supplemental examination proceeding.”

This means that you can file a power of attorney at various stages of the patent process, including:

  • At the time of filing the application
  • After the application has been submitted
  • During prosecution of the application
  • Even after the patent has been granted (for reexamination or supplemental examination proceedings)

However, it’s generally advisable to file the power of attorney as early as possible to ensure smooth communication with the USPTO throughout the application process. If you need to file a power of attorney after submission, use the appropriate USPTO form and follow the current filing procedures.

To learn more:

The timing requirements for submitting an IDS are:

  • Within 3 months of filing or before first Office action, whichever is later
  • Before final Office action, Notice of Allowance, or Quayle action
  • After final Office action but before issue fee payment
  • After issue fee payment but before patent grant

The specific requirements vary based on when the IDS is filed. For example, as stated in MPEP 609.04(b): “An information disclosure statement will be considered by the examiner if filed within any one of the following time periods: (A) for national applications (not including CPAs), within three months of the filing date of the national application or before the mailing date of a first Office action on the merits; (B) for international applications, within three months of the date of entry of the national stage as set forth in 37 CFR 1.491 or before the mailing date of a first Office action on the merits; (C) for RCEs and CPAs, before the mailing date of a first Office action on the merits; or (D) for international design applications, within three months of the date of publication of the international registration under Hague Agreement Article 10(3) or before first Office action on the merits, whichever is later.”

To learn more:

Information Disclosure Statement (IDS) requirements for international design applications designating the United States are similar to those for domestic national applications:

  • The duty to disclose information material to patentability applies to individuals associated with the filing and prosecution of the application.
  • An IDS must adhere to the requirements set forth in 37 CFR 1.97, 1.98, and 1.33(b) for consideration by the examiner.
  • An IDS filed within three months of the publication date of the international registration will be considered by the Office under 37 CFR 1.97(b)(5).
  • IDSs filed after this period may be considered as provided in 37 CFR 1.97.

As stated in the MPEP: An international design application designating the United States has the effect of a U.S. patent application and thus is subject to 37 CFR 1.56.

To learn more:

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

An Information Disclosure Statement (IDS) is a formal document submitted to the USPTO during patent prosecution to disclose relevant prior art or other material information. According to 37 CFR 1.97, as referenced in the MPEP, The provisions of 37 CFR 1.97 specify when an information disclosure statement will be considered as a matter of right and when a certification must be made and/or fee submitted in order to have the information disclosure statement considered.

The IDS is a crucial part of fulfilling the duty of disclosure to the USPTO, ensuring that the patent examiner has all relevant information when considering the patentability of an invention.

To learn more:

Yes, you can request the return of your model, exhibit, or specimen from the USPTO. However, there are specific procedures and timeframes to follow. According to MPEP 608.03(a):

A request for return of the model, exhibit, or specimen should be made within the period set forth in MPEP § 608.03(a).

Here are the key points to remember:

  • Make the request before the application is allowed or within two months after the date of the Notice of Allowance.
  • Include a proper postage paid return address sticker with the request.
  • If the item is not claimed within the specified period, the USPTO may dispose of it at its discretion.

It’s important to act promptly if you wish to have your items returned, as the USPTO is not obligated to store them indefinitely.

To learn more:

Yes, in some cases, omitting information from a patent application can be considered new matter. This might seem counterintuitive, but the removal of certain information can change the scope or meaning of the invention in a way that wasn’t supported by the original disclosure.

The MPEP provides an example: New matter includes not only the addition of wholly unsupported subject matter, but may also include […] even the omission of a step from a method. (MPEP 608.04(a))

This concept is particularly important in the context of:

  • Changing the scope of the invention
  • Altering the nature of the invention
  • Removing essential features or steps

Applicants should be cautious when making any changes to their application, including deletions, to ensure they don’t inadvertently introduce new matter by omission. If in doubt, it’s advisable to consult with a patent attorney or agent.

To learn more:

Tags: new matter, USPTO

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

When filing papers in an ex parte reexamination resulting from a supplemental examination, follow these guidelines as per MPEP 2806:

  • Use the USPTO’s Patent Electronic Filing System-Web (EFS-Web) or Patent Center for electronic filing.
  • For paper filings, send documents to: Mail Stop Ex Parte Reexam, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
  • Include the control number assigned to the reexamination proceeding.
  • Clearly mark all papers with “EX PARTE REEXAMINATION” to ensure proper routing.

The MPEP states: “Any paper filed in an ex parte reexamination proceeding resulting from a supplemental examination proceeding should be filed as provided in 37 CFR 1.1(c).” This ensures that your documents are properly processed and routed within the USPTO.

To learn more:

The USPTO determines if a Substantial New Question of Patentability (SNQ) is raised by reviewing the items of information presented in the supplemental examination request. The examiner considers whether the information would be important to a reasonable examiner in determining patentability.

According to the MPEP: For each item of information, the examiner need only identify one SNQ (e.g., a teaching that would be important to a reasonable examiner when determining patentability) for each identified claim. The determination is made on a claim-by-claim basis, and the examiner must provide a detailed explanation in the Reasons Document.

To learn more:

When submitting a “Sequence Listing XML” in response to a notice from the United States International Searching Authority (ISA) or International Preliminary Examining Authority (IPEA), applicants are required to pay a late furnishing fee. According to MPEP 2414.05:

“In response to such a requirement, the late furnishing fee set forth in § 1.445(a)(5) is also required.”

This fee is in addition to the submission of the “Sequence Listing XML” and a statement that the information does not go beyond the original disclosure. The specific amount of the fee can be found in 37 CFR 1.445(a)(5) and is subject to change, so applicants should consult the current fee schedule on the USPTO website.

To learn more:

When submitting a “Sequence Listing XML” on read-only optical discs, proper labeling and packaging are crucial. According to MPEP 2413.03, follow these guidelines:

  1. Marking: All read-only optical discs, fees, and accompanying papers should be marked “Mail Stop SEQUENCE.”
  2. Hand delivery: For hand delivery to the Customer Service Window, place the disc in a protective mailer labeled with at least the application number (if available).
  3. Labeling requirements: Adhere to the labeling requirements of 37 CFR 1.52(e) and 1.834(b)(2).
  4. Packaging: Use staples and clips carefully to attach the mailer to the submitted papers without contacting or compressing the media.
  5. Multiple discs: If a compressed XML file doesn’t fit on a single disc, it may be split into multiple parts, labeled in compliance with § 1.52(e)(5)(vi).

The MPEP also states: “In no situations should additional or complimentary electronic copies be delivered to examiners or other Office personnel.”

By following these guidelines, you ensure proper handling and processing of your “Sequence Listing XML” submission.

To learn more:

According to 37 CFR 1.1042, applicants can specify a correspondence address for communications sent by the USPTO as an office of indirect filing. The MPEP states:

Pursuant to 37 CFR 1.1042, the applicant may specify a correspondence address for correspondence sent by the USPTO as an office of indirect filing.

This address can be different from the one specified on the official DM/1 form used for filing the international design application. If no specific address is provided, the USPTO will use the address of the applicant’s appointed representative or the address specified in Administrative Instruction 302.

To learn more:

The concepts of a “substantial new question of patentability” (SNQ) and a “prima facie case of unpatentability” are distinct in patent law, particularly in the context of reexamination proceedings. According to MPEP 2242:

It is not necessary that a ‘prima facie’ case of unpatentability exist as to the claim in order for ‘a substantial new question of patentability’ to be present as to the claim.

Key differences include:

  • SNQ: This is the threshold for initiating a reexamination. It exists when prior art raises a substantial question about the patentability of at least one claim, even if it wouldn’t necessarily lead to a rejection.
  • Prima facie case: This is a higher standard, typically used during examination, where the evidence is sufficient to establish unpatentability unless rebutted.

The MPEP notes: Thus, ‘a substantial new question of patentability’ as to a patent claim could be present even if the examiner would not necessarily reject the claim as either fully anticipated by, or obvious in view of, the prior art patents or printed publications.

This distinction allows for a broader range of issues to be considered in reexamination proceedings.

To learn more: